Showing 581-590 of 9653 results for "".
Look to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.Stevens-Johnson Syndrome: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/stevens-johnson-syndrome-a-case-series/23902/Successful treatment of drug-induced Stevens-Johnson Syndrome using cyclosporine and etanercept.Challenges and Opportunities for the Dermatology Specialty
https://practicaldermatology.com/topics/practice-management/challenges-and-opportunities-for-the-dermatology-specialty/23881/Joining together may help address some of the issues facing board-certified dermatologists.Novel PsO Drug Could Be 'Closest Perception of a Cure,' Dr. Strober Says at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/novel-pso-drug-could-be-closest-perception-of-a-cure-dr-strober-says-at-maui-derm/32922/A novel monoclonal antibody targeting IL-23 for the treatment of psoriasis offers an extended half-life that will be a key differentiator for patients, according to Bruce Strober, MD, PhD.DermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dr-bhatia-and-dr-schlesinger-discuss-collaboration-oncologists/26304/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, and Editorial Board member Todd Schlesinger, MD, discuss the importance of collaborating with oncologists on advanced skin cancer cases as immunotherapy technology continues to progress.Science of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.Hidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.JAK Inhibitors in Hidradenitis Suppurativa: A Systematic Review
https://practicaldermatology.com/topics/feature/jak-inhibitors-in-hidradenitis-suppurativa-a-systematic-review/29887/Hidradenitis suppurativa (HS) is a chronic, disfiguring, debilitating, inflammatory disorder that is characterized by inflammatory nodules, abscesses, fistulae/ sinus tracts, and scarring to the axilla, inframammary folds, and groin.